These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11736728)

  • 1. Impairment of cytochrome P-450-dependent liver activity in cirrhotic patients with Helicobacter pylori infection.
    Giannini E; Fasoli A; Borro P; Chiarbonello B; Malfatti F; Romagnoli P; Botta F; Testa E; Fumagalli A; Polegato S; Savarino V; Testa R
    Aliment Pharmacol Ther; 2001 Dec; 15(12):1967-73. PubMed ID: 11736728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.
    Giannini E; Fasoli A; Botta F; Romagnoli P; Malfatti F; Chiarbonello B; Mamone M; Savarino V; Testa R
    Dig Dis Sci; 2003 Apr; 48(4):802-8. PubMed ID: 12741475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies.
    Perri F; Clemente R; Festa V; De Ambrosio CC; Quitadamo M; Fusillo M; Grossi E; Andriulli A
    Ital J Gastroenterol Hepatol; 1999 May; 31(4):290-4. PubMed ID: 10425573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of
    Huang J; Cui J
    Chin Med J (Engl); 2017 Jan; 130(2):149-154. PubMed ID: 28091405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 1-week Helicobacter pylori eradication therapy with rabeprazole, clarithromycin, and metronidazole on 13C-aminopyrine breath test.
    Giannini EG; Malfatti F; Botta F; Polegato S; Testa E; Fumagalli A; Mamone M; Savarino V; Testa R
    Dig Dis Sci; 2005 Jul; 50(7):1207-13. PubMed ID: 16047461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
    Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
    J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis.
    Consolazio A; Borgia MC; Ferro D; Iacopini F; Paoluzi OA; Crispino P; Nardi F; Rivera M; Paoluzi P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):289-94. PubMed ID: 15274665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
    Saruç M; Demir MA; Küçükmetin N; Kandiloglu AR; Akarca US; Yüceyar H
    Hepatogastroenterology; 2002; 49(45):878-81. PubMed ID: 12064012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [13C]urea breath test to confirm eradication of Helicobacter pylori.
    Slomianski A; Schubert T; Cutler AF
    Am J Gastroenterol; 1995 Feb; 90(2):224-6. PubMed ID: 7847290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori infection detected by serology and 13C-urea breath test in HIV-1 perinatally infected children.
    Lionetti P; Amarri S; Silenzi F; Galli L; Cellini M; de Martino M; Vierucci A
    J Pediatr Gastroenterol Nutr; 1999 Mar; 28(3):301-6. PubMed ID: 10067732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying.
    Perri F; Clemente R; Festa V; Annese V; Quitadamo M; Rutgeerts P; Andriulli A
    Am J Gastroenterol; 1998 Nov; 93(11):2082-8. PubMed ID: 9820377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
    García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
    Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children.
    Konstantopoulos N; Rüssmann H; Tasch C; Sauerwald T; Demmelmair H; Autenrieth I; Koletzko S
    Am J Gastroenterol; 2001 Mar; 96(3):677-83. PubMed ID: 11280533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative correlation of Helicobacter pylori stool antigen (HpSA) test with 13C-urea breath test (13C-UBT) by the updated Sydney grading system of gastritis.
    Chang MC; Chang YT; Sun CT; Wu MS; Wang HP; Lin JT
    Hepatogastroenterology; 2002; 49(44):576-9. PubMed ID: 11995501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.